Results 301 to 310 of about 73,040 (325)

Malignant Pleural Mesothelioma

Reference Module in Biomedical Sciences, 2021
A. Scherpereel, Florian Crépin
semanticscholar   +1 more source

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

The Lancet Oncology, 2017
N. van Zandwijk, N. Pavlakis, S. Kao, A. Linton, M. Boyer, S. Clarke, Y. Huynh, A. Chrzanowska, M. Fulham, D. Bailey, W. Cooper, L. Kritharides, L. Ridley, Scott Pattison, J. MacDiarmid, H. Brahmbhatt, G. Reid   +16 more
semanticscholar   +1 more source

Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

Ca-A Cancer Journal for Clinicians, 2010
Erwin G Van Meir, Constantinos G Hadjipanayis, Hui-kuo G Shu   +2 more
exaly  

Childhood cancer survivors face greater risks of subsequent malignant neoplasms from human papillomavirus

Ca-A Cancer Journal for Clinicians, 2022
exaly  

Photodynamic therapy of cancer: An update

Ca-A Cancer Journal for Clinicians, 2011
Patrizia Agostinis, Kristian Berg, Keith A Cengel   +2 more
exaly  

[Malignant pleural mesotheliomas].

Acta medica portuguesa, 1986
V S Vieira, P Gomes, Pina Je, C Ribeiro, L Carreiro   +4 more
openaire   +3 more sources

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.

The Lancet Oncology, 2017
E. Alley, Juanita Lopez, A. Santoro, A. Morosky, S. Saraf, B. Piperdi, E. V. van Brummelen   +6 more
semanticscholar   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Joyce Slingerland, Manuel Picon-ruiz, Cynthia Morata-tarifa   +2 more
exaly  

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi, Federico Gago
exaly  

Novel therapies for malignant pleural mesothelioma.

The Lancet Oncology, 2018
A. Scherpereel, F. Wallyn, S. Albelda, C. Munck   +3 more
semanticscholar   +1 more source